Clinical Trials in Tennessee

Showing 3121-3140 of 20,239 trials

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

NCT00772382

The primary objective of this study is to demonstrate the long-term safety and tolerability of MCI-196 in the subjects with stage V chronic kidney disease on dialysis with hyperphosphatemia. The secondary objective of this study is to assess the long-term efficacy of flexible doses of MCI-196.

Chronic Kidney DiseaseDialysisHyperphosphatemia

Tanabe Pharma Corporation116 participantsStarted Dec 2008

Los Angeles, California, United States • Orange, California, United States • Tarzana, California, United States +18 more locations

RECRUITINGNA29 miles

RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

NCT06455085

RESTORE tests whether Augmented-FLS, where patients are contacted by a patient navigator (serving as the liaison) and referred to a bone health provider, is better than Enhanced Usual Care, which includes patient and PCP education and activation. We also aim to determine the influence of age, race, ethnicity, sex, poverty level, geographic region, and timing of entry into the trial after a fracture on the effectiveness of the two strategies.

OsteoporosisOsteoporotic FracturesFragility Fracture

University of Alabama at Birmingham2,634 participantsStarted Dec 2024

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Gainesville, Florida, United States +18 more locations

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

Find Trials by Condition in Tennessee

A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma

A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer

Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test

Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc

Investigation of the Two Level Simplify® Cervical Artificial Disc

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD)

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

A Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensifentrine-glycopyrrolate Fixed Dose Combination, Ensifentrine, and Glycopyrrolate in Subjects With Chronic Obstructive Pulmonary Disease

STimulation to Activate RespIration

Pragmatic Use of PAIN-Advanced Dementia Scale in Emergency Departments

Human Laboratory Study of Apremilast for Alcohol Use Disorder

Risk Indicators of Sarcoidosis Evolution-Unified Protocol

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors